Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with squamous cell carcinoma of the anal canal (a type of anal cancer) who are scheduled to receive radiotherapy, with or without chemotherapy, as their main treatment
- People aged 18 years or older
- People who have given their agreement to take part, both in writing and verbally
Who may not be able to join:
- People who have a medical condition that would make it unsafe or unsuitable for them to have blood samples taken
- People who have a medical condition that would make it unsafe or unsuitable for them to have a PET-CT scan (a type of imaging scan that looks at how the body is functioning)
- People who may have difficulty following the regular check-up schedule and study requirements over time (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Karen-Lise G Spindler, Professor, Department of Experimental Clinical Oncology Aarhus Univeristy Hospital
Phone: 91137244
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.